Chad Pecot
Founder & Chief Scientific Officer EnFuego Therapeutics
Chad Pecot is a tenured professor at the University of North Carolina where he directs the RNA Discovery Center and the Cancer Therapeutics program. He specializes in thoracic medical oncology and runs a research lab studying the roles of RNA in promoting metastases and the tumor microenvironment. He is also the CSO of EnFuego Therapeutics, which seeks to bring a first-in-class dual targeting RNAi modality to the oncology clinic in 2027.
Seminars
Wednesday 9th September 2026
Next Generation RNAi Therapeutics for Mutant Selective Oncogene Targeting & Dual Target Engagement
9:30 am
- Covering the development of an EGFR-directed RNAi delivery platform
- Discussion on how next generation oligonucleotide chemistries can be utilized for highly specific KRAS mutation selective inhibitors
- Exploration of how newer RNA designs can be used to co-target key combinatorial strategies to enhance efficacy in KRAS mutant cancers
